Do analysts rate NYC or MLEC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Strategic Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer MLEC or REFR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Research Frontiers 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer BIOX or MLEC?

Bioceres Crop Solutions presently has a consensus target price of $4.00, suggesting a potential upside of 1,108.46%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, research analysts plainly believe Bioceres Crop Solutions is more favorable than Moolec Science. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioceres Crop Solutions 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is IVCP or MLEC more profitable?

Moolec Science's return on equity of 0.00% beat Swiftmerge Acquisition's return on equity. Company Net Margins Return on Equity Return on Assets Swiftmerge Acquisition N/A -11.71% -0.23% Moolec Science N/A N/A N/A

Do analysts prefer MDRR or MLEC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medalist Diversified REIT 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Moolec Science (MLEC) Competitors

$7.97 0.00 (0.00%)

Closing price 07/2/2026 03:50 PM Eastern

Extended Trading

$7.89 -0.08 (-0.98%)

As of 08:09 AM Eastern

Compare

MLEC vs. NYC, REFR, BIOX, IVCP, and MDRR

Should you buy Moolec Science stock or one of its competitors? MarketBeat compares Moolec Science with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Moolec Science include American Strategic Investment (NYC), Research Frontiers (REFR), Bioceres Crop Solutions (BIOX), Swiftmerge Acquisition (IVCP), and Medalist Diversified REIT (MDRR). These companies are all part of the "trading" industry.

How does Moolec Science compare to American Strategic Investment?

American Strategic Investment (NYSE:NYC) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

48.0% of American Strategic Investment shares are owned by institutional investors. Comparatively, 0.1% of Moolec Science shares are owned by institutional investors. 4.0% of American Strategic Investment shares are owned by insiders. Comparatively, 19.9% of Moolec Science shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

American Strategic Investment has a beta of 0.19, indicating that its share price is 81% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.26, indicating that its share price is 74% less volatile than the broader market.

In the previous week, American Strategic Investment had 7 more articles in the media than Moolec Science. MarketBeat recorded 7 mentions for American Strategic Investment and 0 mentions for Moolec Science. American Strategic Investment's average media sentiment score of 1.11 beat Moolec Science's score of 0.00 indicating that American Strategic Investment is being referred to more favorably in the media.

Company	Overall Sentiment
American Strategic Investment	Positive
Moolec Science	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Strategic Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

American Strategic Investment has higher earnings, but lower revenue than Moolec Science. American Strategic Investment is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Strategic Investment	$43.28M	0.58	-$21.19M	-$8.45	N/A
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

Moolec Science has a net margin of 0.00% compared to American Strategic Investment's net margin of -53.18%. Moolec Science's return on equity of 0.00% beat American Strategic Investment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Strategic Investment	-53.18%	-113.06%	-14.35%
Moolec Science	N/A	N/A	N/A

Summary

American Strategic Investment and Moolec Science tied by winning 7 of the 14 factors compared between the two stocks.

How does Moolec Science compare to Research Frontiers?

Moolec Science (NASDAQ:MLEC) and Research Frontiers (NASDAQ:REFR) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

In the previous week, Research Frontiers had 1 more articles in the media than Moolec Science. MarketBeat recorded 1 mentions for Research Frontiers and 0 mentions for Moolec Science. Moolec Science's average media sentiment score of 0.00 equaled Research Frontiers'average media sentiment score.

Company	Overall Sentiment
Moolec Science	Neutral
Research Frontiers	Neutral

Moolec Science has a beta of 0.26, suggesting that its share price is 74% less volatile than the broader market. Comparatively, Research Frontiers has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market.

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 11.9% of Research Frontiers shares are held by institutional investors. 19.9% of Moolec Science shares are held by company insiders. Comparatively, 6.5% of Research Frontiers shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Moolec Science has a net margin of 0.00% compared to Research Frontiers' net margin of -343.47%. Moolec Science's return on equity of 0.00% beat Research Frontiers' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Moolec Science	N/A	N/A	N/A
Research Frontiers	-343.47%	-159.20%	-84.93%

Research Frontiers has lower revenue, but higher earnings than Moolec Science. Research Frontiers is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A
Research Frontiers	$1.12M	17.05	-$2.05M	-$0.07	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Research Frontiers	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Research Frontiers beats Moolec Science on 7 of the 13 factors compared between the two stocks.

How does Moolec Science compare to Bioceres Crop Solutions?

Bioceres Crop Solutions (NASDAQ:BIOX) and Moolec Science (NASDAQ:MLEC) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

Moolec Science has a net margin of 0.00% compared to Bioceres Crop Solutions' net margin of -92.85%. Moolec Science's return on equity of 0.00% beat Bioceres Crop Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioceres Crop Solutions	-92.85%	-33.97%	-10.31%
Moolec Science	N/A	N/A	N/A

Bioceres Crop Solutions presently has a consensus target price of $4.00, suggesting a potential upside of 1,108.46%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, research analysts plainly believe Bioceres Crop Solutions is more favorable than Moolec Science.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioceres Crop Solutions	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

17.7% of Bioceres Crop Solutions shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 19.9% of Moolec Science shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Bioceres Crop Solutions has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.26, meaning that its stock price is 74% less volatile than the broader market.

Bioceres Crop Solutions has higher earnings, but lower revenue than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioceres Crop Solutions	$333.30M	0.06	-$55.42M	-$3.86	N/A
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

In the previous week, Bioceres Crop Solutions had 1 more articles in the media than Moolec Science. MarketBeat recorded 1 mentions for Bioceres Crop Solutions and 0 mentions for Moolec Science. Bioceres Crop Solutions' average media sentiment score of 0.44 beat Moolec Science's score of 0.00 indicating that Bioceres Crop Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Bioceres Crop Solutions	Neutral
Moolec Science	Neutral

Summary

Bioceres Crop Solutions beats Moolec Science on 11 of the 16 factors compared between the two stocks.

How does Moolec Science compare to Swiftmerge Acquisition?

Swiftmerge Acquisition (NASDAQ:IVCP) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

Swiftmerge Acquisition has higher earnings, but lower revenue than Moolec Science. Swiftmerge Acquisition is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Swiftmerge Acquisition	N/A	N/A	$3.42M	-$0.02	N/A
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

Moolec Science's return on equity of 0.00% beat Swiftmerge Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Swiftmerge Acquisition	N/A	-11.71%	-0.23%
Moolec Science	N/A	N/A	N/A

Swiftmerge Acquisition has a beta of 0.03, suggesting that its share price is 97% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.26, suggesting that its share price is 74% less volatile than the broader market.

38.1% of Swiftmerge Acquisition shares are owned by institutional investors. Comparatively, 0.1% of Moolec Science shares are owned by institutional investors. 42.9% of Swiftmerge Acquisition shares are owned by insiders. Comparatively, 19.9% of Moolec Science shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Swiftmerge Acquisition had 1 more articles in the media than Moolec Science. MarketBeat recorded 1 mentions for Swiftmerge Acquisition and 0 mentions for Moolec Science. Swiftmerge Acquisition's average media sentiment score of 0.75 beat Moolec Science's score of 0.00 indicating that Swiftmerge Acquisition is being referred to more favorably in the media.

Company	Overall Sentiment
Swiftmerge Acquisition	Positive
Moolec Science	Neutral

Summary

Swiftmerge Acquisition beats Moolec Science on 6 of the 11 factors compared between the two stocks.

How does Moolec Science compare to Medalist Diversified REIT?

Medalist Diversified REIT (NASDAQ:MDRR) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

Medalist Diversified REIT has a net margin of 74.73% compared to Moolec Science's net margin of 0.00%. Moolec Science's return on equity of 0.00% beat Medalist Diversified REIT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medalist Diversified REIT	74.73%	-16.90%	-6.11%
Moolec Science	N/A	N/A	N/A

Medalist Diversified REIT has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.26, suggesting that its stock price is 74% less volatile than the broader market.

17.4% of Medalist Diversified REIT shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 77.6% of Medalist Diversified REIT shares are held by insiders. Comparatively, 19.9% of Moolec Science shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Medalist Diversified REIT has higher earnings, but lower revenue than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Medalist Diversified REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medalist Diversified REIT	$10.40M	1.81	-$2.39M	$3.75	3.07
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medalist Diversified REIT	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Medalist Diversified REIT's average media sentiment score of 0.00 equaled Moolec Science'saverage media sentiment score.

Company	Overall Sentiment
Medalist Diversified REIT	Neutral
Moolec Science	Neutral

Summary

Medalist Diversified REIT beats Moolec Science on 9 of the 12 factors compared between the two stocks.

Get Moolec Science News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLEC vs. The Competition

Export

Metric	Moolec Science	AGRI OPERATIONS Industry	Staples Sector	NASDAQ Exchange
Market Cap	$5.82M	$3.37B	$16.69B	$12.46B
Dividend Yield	N/A	2.86%	3.29%	6.52%
P/E Ratio	-0.24	34.07	26.96	24.70
Price / Sales	0.02	3.81	47.18	98.72
Price / Cash	N/A	8.87	13.44	49.23
Price / Book	-0.03	3.86	5.63	6.49
Net Income	-$111.46M	-$7.36M	$669.01M	$336.25M
7 Day Performance	-1.48%	-1.93%	0.91%	0.35%
1 Month Performance	6.69%	-5.09%	4.47%	3.91%
1 Year Performance	-91.17%	-21.96%	-13.00%	23.88%

Moolec Science Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLEC Moolec Science	N/A	$7.97 flat	N/A	-91.2%	$5.82M	$333.61M	N/A	4	Gap Down
NYC American Strategic Investment	1.4542 of 5 stars	$8.26 +2.5%	N/A	-37.0%	$22.22M	$43.28M	N/A	N/A	News Coverage High Trading Volume
REFR Research Frontiers	0.0511 of 5 stars	$0.62 flat	N/A	-66.2%	$21.69M	$697.79K	N/A	6	Gap Up
BIOX Bioceres Crop Solutions	2.5501 of 5 stars	$0.33 -5.4%	$4.00 +1,130.8%	-93.0%	$20.61M	$333.30M	N/A	500
IVCP Swiftmerge Acquisition	N/A	$2.87 -2.0%	N/A	-57.0%	$19.63M	N/A	N/A	2,021	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MLEC) was last updated on 7/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Moolec Science (MLEC) Competitors

MLEC vs. NYC, REFR, BIOX, IVCP, and MDRR

How does Moolec Science compare to American Strategic Investment?

Summary

How does Moolec Science compare to Research Frontiers?

Summary

How does Moolec Science compare to Bioceres Crop Solutions?

Summary

How does Moolec Science compare to Swiftmerge Acquisition?

Summary

How does Moolec Science compare to Medalist Diversified REIT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLEC vs. The Competition

Moolec Science Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Moolec Science (MLEC) Competitors

MLEC vs. NYC, REFR, BIOX, IVCP, and MDRR

How does Moolec Science compare to American Strategic Investment?

Do insiders and institutionals have more ownership in NYC or MLEC?

Which has more risk & volatility, NYC or MLEC?

Does the media favor NYC or MLEC?

Do analysts rate NYC or MLEC?

Which has higher valuation and earnings, NYC or MLEC?

Is NYC or MLEC more profitable?

Summary

How does Moolec Science compare to Research Frontiers?

Does the media favor MLEC or REFR?

Which has more risk & volatility, MLEC or REFR?

Do insiders & institutionals have more ownership in MLEC or REFR?

Is MLEC or REFR more profitable?

Which has higher earnings and valuation, MLEC or REFR?

Do analysts prefer MLEC or REFR?

Summary

How does Moolec Science compare to Bioceres Crop Solutions?

Is BIOX or MLEC more profitable?

Do analysts prefer BIOX or MLEC?

Do institutionals and insiders hold more shares of BIOX or MLEC?

Which has more volatility & risk, BIOX or MLEC?

Which has better earnings & valuation, BIOX or MLEC?

Does the media refer more to BIOX or MLEC?

Summary

How does Moolec Science compare to Swiftmerge Acquisition?

Which has higher earnings & valuation, IVCP or MLEC?

Is IVCP or MLEC more profitable?

Which has more risk & volatility, IVCP or MLEC?

Do institutionals and insiders believe in IVCP or MLEC?

Does the media refer more to IVCP or MLEC?

Summary

How does Moolec Science compare to Medalist Diversified REIT?

Is MDRR or MLEC more profitable?

Which has more risk & volatility, MDRR or MLEC?

Do institutionals and insiders have more ownership in MDRR or MLEC?

Which has better valuation & earnings, MDRR or MLEC?

Do analysts prefer MDRR or MLEC?

Does the media favor MDRR or MLEC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLEC vs. The Competition

Moolec Science Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools